Werewolf Therapeutics, Inc. - Common Stock (HOWL)

45 filings reported holding HOWL - Werewolf Therapeutics, Inc. - Common Stock as of Q2 2021.
Werewolf Therapeutics, Inc. - Common Stock (HOWL) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19.8M shares of 48.5M outstanding shares and own 40.73% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.29M shares), MPM ASSET MANAGEMENT LLC (4.28M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.55M shares), MPM Oncology Impact Management LP (2.39M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1M shares), SPHERA FUNDS MANAGEMENT LTD. (706K shares), Avidity Partners Management LP (650K shares), DC Funds, LP (589K shares), Soleus Capital Management, L.P. (563K shares), and PFM Health Sciences, LP (400K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.